DexCom, Inc. (DXCM)
78.19
+1.57
(+2.05%)
USD |
NASDAQ |
Jun 09, 16:00
78.39
+0.20
(+0.26%)
After-Hours: 20:00
DexCom SG&A Expense (Quarterly) : 349.70M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insulet Corp. | 317.20M |
| Abbott Laboratories | 3.74B |
| Globus Medical, Inc. | 297.78M |
| Baxter International, Inc. | 728.00M |
| Boston Scientific Corp. | 1.781B |